GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » EV-to-FCF

Curocell (XKRX:372320) EV-to-FCF : (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Curocell's Enterprise Value is ₩439,603.16 Mil. Curocell does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023. Therefore, GuruFocus does not calculate Curocell's EV-to-FCF at this moment.

The historical rank and industry rank for Curocell's EV-to-FCF or its related term are showing as below:

XKRX:372320' s EV-to-FCF Range Over the Past 10 Years
Min: -48.03   Med: 0   Max: 0
Current: -9.5
XKRX:372320's EV-to-FCF is ranked worse than
100% of 378 companies
in the Biotechnology industry
Industry Median: 8.345 vs XKRX:372320: -9.50

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Curocell's stock price is ₩31600.00. Curocell does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023. Therefore, GuruFocus does not calculate Curocell's PE Ratio at this moment.

Curocell EV-to-FCF Historical Data

The historical data trend for Curocell's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell EV-to-FCF Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - - - -10.41

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
EV-to-FCF - - - -10.41

Competitive Comparison of Curocell's EV-to-FCF

For the Biotechnology subindustry, Curocell's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Curocell's EV-to-FCF falls into.


Curocell EV-to-FCF Calculation

Curocell's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=439603.155/
=

Curocell  (XKRX:372320) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Curocell's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=31600.00/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Curocell EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Curocell's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » EV-to-FCF
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines